JP2021001178A5 - - Google Patents

Download PDF

Info

Publication number
JP2021001178A5
JP2021001178A5 JP2020143608A JP2020143608A JP2021001178A5 JP 2021001178 A5 JP2021001178 A5 JP 2021001178A5 JP 2020143608 A JP2020143608 A JP 2020143608A JP 2020143608 A JP2020143608 A JP 2020143608A JP 2021001178 A5 JP2021001178 A5 JP 2021001178A5
Authority
JP
Japan
Prior art keywords
cell
isolated placental
cells
placental
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020143608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021001178A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021001178A publication Critical patent/JP2021001178A/ja
Publication of JP2021001178A5 publication Critical patent/JP2021001178A5/ja
Priority to JP2022143365A priority Critical patent/JP2022184911A/ja
Withdrawn legal-status Critical Current

Links

JP2020143608A 2014-09-26 2020-08-27 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療 Withdrawn JP2021001178A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022143365A JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201462056008P 2014-09-26 2014-09-26
US62/056,008 2014-09-26
US201562145551P 2015-04-10 2015-04-10
US62/145,551 2015-04-10
US201562151726P 2015-04-23 2015-04-23
US62/151,726 2015-04-23
US201562170757P 2015-06-04 2015-06-04
US62/170,757 2015-06-04
US201562220620P 2015-09-18 2015-09-18
US62/220,620 2015-09-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017516161A Division JP2017537057A (ja) 2014-09-26 2015-09-25 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022143365A Division JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Publications (2)

Publication Number Publication Date
JP2021001178A JP2021001178A (ja) 2021-01-07
JP2021001178A5 true JP2021001178A5 (https=) 2022-03-02

Family

ID=55582072

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017516161A Pending JP2017537057A (ja) 2014-09-26 2015-09-25 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2020143608A Withdrawn JP2021001178A (ja) 2014-09-26 2020-08-27 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療
JP2022143365A Pending JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017516161A Pending JP2017537057A (ja) 2014-09-26 2015-09-25 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022143365A Pending JP2022184911A (ja) 2014-09-26 2022-09-09 胎盤幹細胞を使用する糖尿病性足部潰瘍の治療

Country Status (4)

Country Link
US (1) US20170290861A1 (https=)
EP (1) EP3197467A4 (https=)
JP (3) JP2017537057A (https=)
WO (1) WO2016049485A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113116933A (zh) * 2021-04-26 2021-07-16 河北医科大学第四医院 一种防治糖尿病足的干细胞组合物及其应用
CN114404590A (zh) * 2022-01-24 2022-04-29 四川大学华西医院 TGF-β抑制剂在制备治疗糖尿病足的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101622007A (zh) * 2006-10-06 2010-01-06 人类起源公司 天然(端肽)胎盘胶原组合物
DK2556145T3 (en) * 2010-04-07 2016-11-07 Anthrogenesis Corp Angiogenesis using placental stem cells
US20120171161A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof

Similar Documents

Publication Publication Date Title
Silini et al. Perinatal derivatives: where do we stand? A roadmap of the human placenta and consensus for tissue and cell nomenclature
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
CO2021006362A2 (es) Construcciones de ácido nucleico y métodos de uso
AU2021203074A1 (en) Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan
EA201100663A1 (ru) Соединения, которые увеличивают количество гематопоэтических стволовых клеток
CR20200392A (es) Anticuerpos anti-cd73 y métodos de uso de los mismos
JP2021001178A5 (https=)
SA519401455B1 (ar) طريقة لعزل الخلايا الجذعية اللحمية المتوسطية من الغشاء السلوي للحبل السري باستخدام مستنبت خلايا متوسطية
SA517390590B1 (ar) Ix عامل معدل، وتركيبات وطرق واستخدامات لنقل الجين إلى الخلايا، والأعضاء والأنسجة
CO2020015707A2 (es) Casetes de expresión de α-glucosidasa de ácido optimizado con codón y métodos de uso del mismo
BR112018076306A2 (pt) composições e métodos para a supressão de células cd117+
WO2021127200A8 (en) Ilt3-binding agents and methods of use thereof
MX2022005249A (es) Anticuerpos anti-cd45 y conjugados de los mismos.
MX2009009414A (es) Obtencion, aislamiento y crioconservacion de celulas endometriales/menstruales.
JP2021527039A5 (https=)
WO2021262597A3 (en) Lair-1-binding agents and methods of use thereof
MX2016016756A (es) Terapia con células madre en patologías endometriales.
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
CL2022003012A1 (es) Anticuerpos anti-dectina-2
WO2006039396A3 (en) Non-embedded tissue microarray technology for protein and nucleic acid analyses
JP2013177444A (ja) ヒトｉＰＳのＴ細胞再分化テロメア若返り炎症老化止めｐ５３とＲｂ分解経口不老不死薬５
ECSP22004680A (es) Anticuerpos anti-angpt2
CY1125389T1 (el) Θετικα κατα abc5 μεσεγχυματικα βλαστοκυτταρα ως ανοσοτροποποιητες
AR120352A1 (es) Anticuerpos anti-cd45 y sus conjugados
PL378431A1 (pl) Sposób rekonstrukcji centralnego narządu immunologicznego u ludzi pozbawionych grasicy lub w stanach wyczerpania immunologicznego